4:59 NewCo, a 5AM Ventures Company
Biotechnology Research
Boston, Ma, United States
24 employees
- Employees
- 24
- Contacts
- 3
- Emails
- 3
- Phones
- 2
4:59 NewCo, a 5AM Ventures Company Overview
- Headquarters
- Boston, Ma, United States
- Website
- 5amventures.com
- Industry
- Biotechnology Research
- Employees
- 24
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About 4:59 NewCo, a 5AM Ventures Company
4:59 is a hands-on internal effort of 5AM Ventures to discover, incubate, and fund breakthrough science. We seek to partner alongside academics and entrepreneurs --often serving as an extension of the operating team -- to establish proof-of-concept data that will enable a Series A Financing.
4:59 NewCo, a 5AM Ventures Company Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 2
- 50.0% coverage
4:59 NewCo, a 5AM Ventures Company Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Daniel Tate | Biotech - Intellectual Property | Cambridge, Massachusetts, United States |
Email
|
| Andrew Denninger | Senior Scientist at 4:59 Newco, a 5am | Arlington, Massachusetts, United States |
Email
Phone
|
| Grinal Corriea | Scientific Consultant @ Venture Capital |
View
|
|
| Dazhi Tan | Discovering Drugs at the Intersection | Greater Boston, United States |
Email
Phone
|
Employees by Management Level
Individual contributor
3 profiles
Senior / Lead
1 profile
Compare Similar Companies to 4:59 NewCo, a 5AM Ventures Company
Flagship Pioneering
Biotechnology Research
RA Capital Management
Financial Services
Atlas Venture
Venture Capital And Private Equity Principals
F-Prime
Venture Capital And Private Equity Principals
Third Rock Ventures
Venture Capital And Private Equity Principals
ARCH Venture Partners
Venture Capital And Private Equity Principals
Foresite Capital
Venture Capital And Private Equity Principals
Precede Biosciences
Biotechnology Research
5AM Ventures
Venture Capital And Private Equity Principals
Renasant Bio
Biotechnology Research